Base Pair Biotechnologies, Inc.

Facebook Twitter LinkedIn

BasePair (www.basepairbio.com) is the premier provider of custom aptamer discovery services. Aptamers are often called "synthetic antibodies." That is an oversimplification, but aptamers have a number of unique advantages over antibodies as molecules that specifically bind other biomolecules, small-molecule drugs and antibiotics, and even whole viruses and bacteria. We discover these DNA- and RNA-based affinity reagents and help our customers build them into products ranging from wearable biosensors and assays to active pharmaceuticals and drug delivery agents. More than 35 years after aptamers were first described in 1990, the world is beginning to see the broad promise of this modality in biotechnology, AgTech, and even consumer markets. 

Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request